Growth Metrics

Maravai Lifesciences Holdings (MRVI) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$1.05.

  • Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) rose 73.53% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year increase of 48.78%. This contributed to the annual value of -$1.05 for FY2024, which is 16.67% down from last year.
  • Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) amounted to -$1.05 in FY2024, which was down 16.67% from -$0.90 recorded in FY2023.
  • Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $2.36 during FY2020, with a 5-year trough of -$1.05 in FY2024.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.09, with a median of -$0.90 in 2023.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 7,966.67% in 2020, then plummeted by 153.89% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) (Yearly) stood at $2.36 in 2020, then plummeted by 33.90% to $1.56 in 2021, then grew by 7.05% to $1.67 in 2022, then plummeted by 153.89% to -$0.90 in 2023, then fell by 16.67% to -$1.05 in 2024.